Ascensia Diabetes Care and Glooko, a remote patient monitoring platform for diabetes has announced an integration partnership to improve diabetes data management and analytics. The integration includes Glooko's Diabetes Data Management Platform and Ascensia's blood glucose monitoring systems that will allow people with diabetes and health care professionals to access and analyze highly accurate blood glucose data through the digital platform of their choice. The collaboration includes all
Read More
Type 2 Diabetes - Chronic Disease Management | News, Analysis, Insights - HIT Consultant
Common Sensing, Welkin Health Partner to Develop Innovative Insulin Adherence Program
Insulin adherence remains a significant challenge with approximately 62 percent of patients discontinuing insulin in the first three months and 82 percent in the first year. To resolve this challenge, Common Sensing and Welkin Health have partnered to develop an innovative new program aimed at improving insulin adherence for people living with diabetes. A first-of-its-kind initiative, the program will combine insulin dosing data, wirelessly transmitted from Common Sensing’s Gocap™, real-time
Read More
Grady Health Goes Live on Glytec’s Personalized Diabetes Therapy Management Platform
Atlanta’s Grady Health System has implemented the Glytec eGlycemic Management System®, a personalized diabetes therapy management solution seamlessly integrated with the Epic EMR. Glytec's eGMS® is currently deployed across all critical care areas -- each assigned an interdisciplinary team of pharmacy, medical and nursing staff to provide localized glycemic governance.Integration with Epic EMReGMS integration with Epic's EMR will allow users direct access from a patient’s chart without the need
Read More
WellDoc Receives FDA 510(k) Clearance for Non-Prescription Version of BlueStar® Digital Therapeutic
Digital health leader WellDoc has received FDA 510(k) class II clearance for a non-prescription version of the BlueStar® digital therapeutic diabetes management platform. This news comes on the heels of two other significant recent announcements for BlueStar®: the FDA’s clearance of the wireless integration of LifeScan’s OneTouch Verio Flex® blood glucose monitoring system with BlueStar®, and plans to incorporate the American Association of Diabetes Educators’ (AADE) curriculum in the BlueStar®
Read More
FDA Clears Wireless Integration of LifeScan’s OneTouch With WellDoc’s Diabetes Management Platform
The U.S. Food and Drug Administration (FDA) announced it has cleared the wireless integration of the OneTouch Verio Flex® blood glucose monitoring system with WellDoc Inc.'s clinically validated diabetes management platform, BlueStar®. The integration will create an integrated, connected experience for people with Type 2 diabetes and deliver value for healthcare providers. Integration DetailsUsing blood glucose data wirelessly and automatically transmitted from the OneTouch Verio Flex blood
Read More
Yes Health and Solera Health Partner to Provide On-Demand Mobile Diabetes Prevention Tools
Yes Health, an all-mobile program to prevent type 2 diabetes has teamed up with Solera Health, an integrator of chronic disease prevention and management solutions to provide on-demand mobile diabetes prevention tools and resources to millions of eligible health plan members. The strategic partnership will enable qualified, at-risk patients with access to Yes Health's Centers for Disease Control and Prevention (CDC)-recognized Diabetes Prevention Program (DPP), as a covered medical benefit.Under
Read More
WellDoc, LifeScan Integrate to Create Type 2 Diabetes Management Platform
WellDoc has entered a commercial partnership agreement with LifeScan Inc., a Johnson & Johnson Diabetes Care Company (JJDCC), to deliver a best-in-class digital health solution for individuals living with Type 2 diabetes. The combined offering will seek to create a comprehensive, data-driven and payer-reimbursed program for Type 2 diabetes management.WellDoc’s BlueStar® diabetes management platform and mobile app is the first digital therapeutic approved by the U.S. Food and Drug
Read More
Anthem Blue Cross Taps Solera Health for Diabetes Prevention Platform
Anthem Blue Cross has launched a diabetes prevention program to educate, treat and support its members who are at risk of developing type 2 diabetes. Pre-diabetes is a condition in which blood glucose levels are higher than normal but not high enough to be considered diabetes. The yearlong program, provided in conjunction with diabetes prevention program integrator Solera Health, offers healthy lifestyle coaching and weekly classes to teach members the skills needed to lose weight, become more
Read More
WellDoc, Human API Partner To Integrate Type 2 Diabetes Patient Data
Digital health technology company WellDoc has announced a partnership with health data platform Human API to integrate type 2 diabetes patient health data within WellDoc’s BlueStar digital therapeutic. As part of the collaboration, Human API’s data platform will provide WellDoc with real-time access to comprehensive clinical patient data from its network of 15,000+ pharmacies, health systems and laboratories. The steady flow of data is shared within a highly secure environment that ensures
Read More
AMA, Omada Health, Intermountain Healthcare Launch Digital Health Program to Reduce Type 2 Diabetes
The American Medical Association (AMA), Omada Health, and Intermountain Healthcare today announced a digital health initiative aimed at reducing the alarming number of adults who develop type 2 diabetes. The new partnership will create a roadmap for large health care organizations across the country to adopt proven online behavior change interventions for at-risk patients, and integrate those programs into provider referral and clinical workflow. The collaboration marks the first time that the
Read More